Aidence, an Amsterdam, The Netherlands-based medical imaging startup, completed a €10m Series A funding round.
The round, which brought total funding to €12.5m, was led by Inkef Capital with participation from Rabo Ventures, alongside existing investors Northzone, HenQ and Health Innovations.
The company intends to use the funds to:
– continue its European market expansion,
– build towards FDA clearance to enter the US healthcare market, and
– explore new avenues for the Veye platform.
Founded in 2015 by Mark-Jan Harte (CEO) and Jeroen van Duffelen (COO), Aidence provides Veye Chest, an AI-enabled pulmonary nodule management assistant, which connects with existing imaging infrastructure and enables radiologists to spot and track changes in pulmonary nodules.
Veye Chest is already installed in more than 10 hospitals in the Netherlands, United Kingdom and Scandinavia and processes hundreds of studies per week.